# Unite.AI — Google DeepMind’s AlphaGenome 2 Predicts Cell-State Variant Effects

- Company: Unite.AI (unite.ai)
- Announced: 2026-11-11T15:28:02+00:00
- Category: new-model
- Coverage: not counted
- Announcement: yes
- Group: models
- Source: https://www.unite.ai/google-deepminds-alphagenome-2-predicts-cell-state-variant-effects/
- Record: https://forck.live/items/34667-google-deepmind-s-alphagenome-2-predicts-cell-state-variant-effects
- Subject: Reporting
- Models affected: AlphaGenome 2, AlphaGenome 1, AlphaGenome Atlas
- License: non-commercial research
- Pricing: non-commercial API use is free and query rates vary with demand

Google DeepMind announced AlphaGenome 2 on November 11, 2026, a deep-learning model that predicts how DNA variants affect gene regulation in individual cell types and states. The model is trained on more than 100 million individual cell profiles and is available for non-commercial research, with commercial research in private preview. It addresses a blind spot in tissue-wide genomic models, where a variant that matters only in a specialized or disease-activated cell has its signal diluted in a tissue average. AlphaGenome 2 conditions each prediction on a selected tissue, cell type or cell state, including conditions generated from a researcher's own single-cell experiment, and adds CpG DNA methylation to the original model's readouts. On the TenK10K single-cell immune dataset spanning 28 cell types, DeepMind's paper reports it recovered 30% of putatively causal expression-linked variants at 90% precision, against 16% for AlphaGenome 1 fine-tuned on single-cell data. DeepMind precomputed an enhancer-gene map across 640 primary single-cell reference conditions and scores for more than 6.8 million variants across 510 human conditions. The paper cautions that the model recovers only a minority of nominated variants, can underestimate effects outside accessible chromatin, and that condition representations capture correlations rather than causal relationships.

## Evidence

Verbatim from https://www.unite.ai/google-deepminds-alphagenome-2-predicts-cell-state-variant-effects/:

> Google DeepMind announced AlphaGenome 2 on November 11, 2026, a deep-learning model that predicts how DNA variants affect gene regulation in individual cell types and states. Trained on more than 100 million individual cell profiles, it is available for non-commercial research and in private preview for commercial research.
> 
> The release addresses a blind spot in tissue-wide genomic models: a variant can matter only in a specialized cell or in a cell activated by disease, leaving its signal diluted in a tissue average. AlphaGenome 2 instead conditions each prediction on a selected tissue, cell type or cell state, including conditions generated from a researcher’s own single-cell experiment.
> 
> The earlier AlphaGenome 1 predicted molecular activity across broad tissues, while AlphaGenome Atlas offered predictions for all 9 billion possible single-letter changes in the human genome. AlphaGenome 2 is a separate model release, not an extension of that precomputed atlas.
> 
> A Model Conditioned on Cell Identity
> 
> AlphaGenome 1 generated fixed outputs for bulk tissues and cell lines simultaneously from a one-million-letter DNA sequence.

---

Record: https://forck.live/items/34667-google-deepmind-s-alphagenome-2-predicts-cell-state-variant-effects
Catalogue: https://forck.live/llms.txt
Current issue: https://forck.live/feed.md
